Berlin's Helmholtz molecular medicine institute, whose cancer research spans T-cell receptor therapies, single-cell biology and systems medicine.
Founded in 1992 on the Berlin-Buch campus, the Max Delbrück Center is a Helmholtz Association institute that works closely with Charité through the Experimental and Clinical Research Center and the Berlin Institute of Health. Thomas Blankenstein's group developed T-cell receptor gene therapy approaches that led to the spin-out T-knife, and the Berlin Institute for Medical Systems Biology under Nikolaus Rajewsky is a centre for single-cell and spatial transcriptomics. Other groups study cancer genomics, oncogenic signalling, tumour immunology and MYC-driven lymphoma. The centre contributes to the DKTK and the German Human Cell Atlas efforts.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-16.
Matched to Max Delbrück Center, including child institutions. 146 works · 1,736 citations · 84% open access · 9% clinical trials · 1% reviews.
Stem-cell and pancreas biologist who has led the Max Delbrück Center as Scientific Director since November 2022.
Systems biologist at the MDC known for microRNA and circular RNA discoveries and for single-cell and spatial genomics applied to cancer.
Shares CZ CELLxGENE / Human Cell Atlas, CRISPR functional genomics, Single-cell & spatial profiling.
Shares CZ CELLxGENE / Human Cell Atlas, CRISPR functional genomics, Single-cell & spatial profiling, Melanoma.
Shares CZ CELLxGENE / Human Cell Atlas, Single-cell & spatial profiling.
Shares TCR-T cell therapy, Melanoma, Colorectal cancer.
Shares CRISPR functional genomics, RNA sequencing & expression profiling.
Shares German Cancer Research Center (DKFZ), Colorectal cancer.